Japanese pharma firm permits commercialisation of GI drug in India
Japan-based Takeda Pharmaceuticals entered into non-exclusive patent licensing agreements to commercialise Vonoprazan tablets with Sun Pharma and Cipla.
japanese firms
June 2024
December 2019
‘Industry should be back on track after April’
Despite slowdown blues, Mitsubishi Electric’s Rajeev Sharma says India is better compared to markets like the U.S. and Europe.
